Clinical Trials Browser

Interventional × viscum album peptide × Genitourinary × Clear all

NCT02106572 2025-07-23

TIM

Phase 3 Active not recruiting

Non-Muscle Invasive Bladder Neoplasms

NCT02007005 2015-05-06

Maximum Tolerable Concentration of abnobaVISCUM Fraxini Intravesically in Patients With Superficial Bladder Cancer

Phase 1/2 Completed

Non-Muscle Invasive Bladder Neoplasms